Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2019

Apr 8, 2019

6990_dirs_2019-04-08_d69f357c-43cb-430f-87d0-a97c1a5137ca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2019-04-08

Reporting Person: SHORRER DORON (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-04-08 Common Stock P 14286 $0.70 Acquired 464744 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-04-08 Common Stock Warrant $0.70 P 14286 Acquired 2024-04-08 Common Stock (14286) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 432500 Indirect

Footnotes

F1: The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of common
stock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I.

F2: The common stock warrants were exercisable immediately upon their issuance.